Acuña Mariana, Martínez Pablo, Moraga Carol, He Xingxuan, Moraga Mauricio, Hunter Bessie, Nuernberg Peter, Gutiérrez Rodrigo A, González Mauricio, Schuchman Edward H, Santos José Luis, Miquel Juan Francisco, Mabe Paulina, Zanlungo Silvana
Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
FONDAP Center for Genome Regulation (CGR), Santiago, Chile.
Eur J Hum Genet. 2016 Feb;24(2):208-13. doi: 10.1038/ejhg.2015.89. Epub 2015 Apr 29.
Niemann-Pick disease type B (NPDB) is a rare, inherited lysosomal storage disorder that occurs due to variants in the sphingomyelin phosphodiesterase 1 (SMPD1) gene and the resultant deficiency of acid sphingomyelinase (ASM) activity. While numerous variants causing NPDB have been described, only a small number have been studied in any detail. Herein, we describe the frequency of the p.(Ala359Asp) variant in the healthy Chilean population, and determine the haplotype background of homozygous patients to establish if this variant originated from a common founder. Genomic DNA samples from 1691 healthy individuals were analyzed for the p.(Ala359Asp) variant. The frequency of p.(Ala359Asp) was found to be 1/105.7, predicting a disease incidence of 1/44 960 in Chile, higher than the incidence estimated by the number of confirmed NPDB cases. We also describe the clinical characteristics of 13 patients homozygous for p.(Ala359Asp) and all of them had moderate to severe NPDB disease. In addition, a conserved haplotype and shared 280 Kb region around the SMPD1 gene was observed in the patients analyzed, indicating that the variant originated from a common ancestor. The haplotype frequency and mitochondrial DNA analysis suggest an Amerindian origin for the variant. To assess the effect of the p.(Ala359Asp) variant, we transfected cells with the ASM-p.(Ala359Asp) cDNA and the activity was only 4.2% compared with the wild-type cDNA, definitively demonstrating the causative effect of the variant on ASM function. Information on common variants such as p.(Ala359Asp) is essential to guide the successful implementation for future therapies and benefit to patients.
B型尼曼-匹克病(NPDB)是一种罕见的遗传性溶酶体贮积症,由鞘磷脂磷酸二酯酶1(SMPD1)基因变异以及由此导致的酸性鞘磷脂酶(ASM)活性缺乏引起。虽然已描述了许多导致NPDB的变异,但只有少数变异得到了详细研究。在此,我们描述了健康智利人群中p.(Ala359Asp)变异的频率,并确定了纯合患者的单倍型背景,以确定该变异是否源自共同的奠基者。对1691名健康个体的基因组DNA样本进行了p.(Ala359Asp)变异分析。发现p.(Ala359Asp)的频率为1/105.7,预测智利的疾病发病率为1/44960,高于根据确诊NPDB病例数估计的发病率。我们还描述了13名p.(Ala359Asp)纯合患者的临床特征,他们均患有中度至重度NPDB疾病。此外,在分析的患者中观察到一个保守的单倍型以及SMPD1基因周围共享的280Kb区域,表明该变异源自共同祖先。单倍型频率和线粒体DNA分析表明该变异起源于美洲印第安人。为了评估p.(Ala359Asp)变异的影响,我们用ASM-p.(Ala359Asp) cDNA转染细胞,其活性与野生型cDNA相比仅为4.2%,明确证明了该变异对ASM功能的致病作用。关于p.(Ala359Asp)等常见变异的信息对于指导未来治疗的成功实施和使患者受益至关重要。